Government news, all in one place
Government news, all in one place
787 articles
Showing 61-90
Thursday, 25 September 2025
New National Commission unites clinical leaders, patient advocates and leading tech firms to make the NHS the most AI-enabled healthcare system in wo...
Tuesday, 23 September 2025
Paracetamol should be taken as directed in the patient information leaflet...
Wednesday, 17 September 2025
The appointment will involve a time commitment of approximately 22 days per year including 11 meetings. Remuneration for the roles will be at a rate o...
Tuesday, 16 September 2025
The importance of medicine safety and how to report side effects of medicines via the Yellow Card scheme is now part of the statutory guidance for sch...
Tuesday, 16 September 2025
As part of developing its new five-year strategy, the MHRA is publishing a series of blogs on the challenges and opportunities ahead. In the first ins...
Tuesday, 16 September 2025
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 16th September 2025, approved the medicine vorasidenib (Voranigo). ...
Wednesday, 03 September 2025
Patients implanted with affected devices should expect to be contacted directly for a follow-up assessment, if required....
Wednesday, 27 August 2025
As with any medicine, the MHRA will keep the safety of gepotidacin under close review....
Wednesday, 27 August 2025
As with any medicine, the MHRA will keep the safety of zuranolone under close review....
Wednesday, 27 August 2025
The pilot will help sponsors prepare for a new substantial modifications process under upcoming regulations, with responses delivered within 14 days....
Monday, 18 August 2025
Parents and caregivers who have purchased Nutrition Ignition Kids Magnesium Glycinate Gummies should stop giving them to children and safely dispose o...
Thursday, 14 August 2025
As with any medicine, the MHRA will keep the safety and effectiveness of teplizumab under close review. ...
Friday, 08 August 2025
WHO recognition affirms MHRA’s commitment to regulatory excellence, innovation and global collaboration...
Thursday, 07 August 2025
The microscopic bacteria living in women’s bodies could be a powerful tool for personalised, non-invasive treatment and earlier diagnosis....
Wednesday, 06 August 2025
Under a joint information sharing agreement, pharmaceutical companies will be invited to register early with the MHRA and NICE to allow parallel decis...
Wednesday, 06 August 2025
Updates on regulatory reform and plans to support innovation....
Monday, 04 August 2025
New jobs to strengthen innovation, safety and smarter regulation across the UK health and life sciences sector. ...
Wednesday, 30 July 2025
Statement of Policy Intent sets out initial thinking on a new Early Access service to help patients benefit sooner from innovative medical devices tha...
Monday, 28 July 2025
The approval is supported by a study involving 453 adults with advanced platinum-resistant cancers of the ovary, fallopian tubes and the peritoneum th...
Monday, 28 July 2025
New genetic therapy approved for SOD1-ALS brings targeted treatment option to patients in the UK...
Thursday, 24 July 2025
A new regional centre to promote Yellow Card reporting has been launched in Belfast today....
Wednesday, 23 July 2025
As the UK enters the heart of summer – with temperatures rising and families holidaying –?the Medicines and Healthcare products Regulatory Agency (MHR...
Tuesday, 22 July 2025
New regulations effective today will make it faster and easier for cutting-edge cancer treatments and personalised gene therapies to be made right whe...
Tuesday, 22 July 2025
The MHRA has now published the government’s response to its public consultation on future routes to market for medical devices - designed to modernise...
Tuesday, 22 July 2025
Ensuring the seasonal flu vaccine is ready, safe and effective involves months of international planning, testing and collaboration...
Monday, 21 July 2025
The Medicines and Healthcare products Regulatory Agency (MHRA) has published its 2024–25 Annual Report and Accounts, and accompanying Impact Report....
Friday, 18 July 2025
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 18 July 2025, approved adrenaline (epinephrine) nasal spray (EURneffy) to be...
Thursday, 17 July 2025
Two board members have been reappointed for two years, while three others have had their term extended by a year....
Wednesday, 16 July 2025
The Life Sciences Sector plan was released today (16 July 2025)...
Tuesday, 15 July 2025
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 15 July 2025, approved sebetralstat (Ekterly) for the treatment of hereditar...